Articles
Tunnah’s musings: 9.63 seconds

Tunnah’s musings: 9.63 seconds

In Paul Tunnah’s latest musings he reminisces on the many great images from the 2012 London Olympics and the inspiration they provide for pharma and healthcare. You can sense the collective hangover dawning on people now that the 2012 Olympic Games have finally drawn to a close. For the past few weeks London has…

Articles
Pharma gets social: was Facebook page responsible for K-V Pharmaceutical Chapter 11 bankruptcy?

Pharma gets social: was Facebook page responsible for K-V Ph...

Following K-V Pharma’s recent filing for bankruptcy, Daniel Ghinn takes a look at the part social media played and shares his thoughts on just how important it is for pharma companies to have a social media strategy in place. “WOOT! I feel bad celebrating anyone losing needed jobs, but this company has to GO... what they tried to do to women...

Articles
Realising the potential of stratified medicine

Realising the potential of stratified medicine

Bob Damms and Hakim Yadi discuss the potential of stratified medicine – the first step towards personalised medicines. The potential of stratified medicine has long been talked about, but the pace of development has increased dramatically...

Sales & Marketing

Digital

Market Access

Editor's Picks

  1. ESMO26: Tango sees 82% ORR with combo in pancreatic cancer
  2. Roche offers $15bn for strategic-level deal with Hansoh
  3. ESMO26: Moderna, MSD reveal cancer jab data early after leak
  4. Clinical trial setup times fall sharply in UK
  5. Despite US policy changes, drug prices stay stubbornly high

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more